Zeo ScientifiX, Inc. (ZEOX) stock
ZEOXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
$0.91+0.00 (+0.15%)
Close on Oct 19, 2026Market cap $7.08MP/E –Yield –
Zeo ScientifiX total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Zeo ScientifiX's total debt was $247.00K at Apr 30, 2026. For fiscal 2025 it was $243.00K, down 64.3% from the year before. The highest annual figure on record is $680.00K in fiscal 2024.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $243.00K | -64.3% |
| FY2024 | Oct 31, 2024 | $680.00K | +3.5% |
| FY2023 | Oct 31, 2023 | $657.00K | +2198.2% |
| FY2022 | Oct 31, 2022 | $28.59K | -79.6% |
| FY2021 | Oct 31, 2021 | $140.43K | +108.6% |
| FY2020 | Oct 31, 2020 | $67.32K | -56.1% |
| FY2019 | Oct 31, 2019 | $153.18K | – |
| FY2018 | Oct 31, 2018 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ1 2026 | Apr 30, 2026 | $247.00K | -64.3% |
| Q1 FY2026CQ4 2025 | Jan 31, 2026 | $245.00K | -64.3% |
| Q4 FY2025CQ3 2025 | Oct 31, 2025 | $243.00K | -64.3% |
| Q3 FY2025CQ2 2025 | Jul 31, 2025 | $698.00K | +4.3% |
| Q2 FY2025CQ1 2025 | Apr 30, 2025 | $692.00K | +4.4% |
| Q1 FY2025CQ4 2024 | Jan 31, 2025 | $686.00K | +4.4% |
| Q4 FY2024CQ3 2024 | Oct 31, 2024 | $680.00K | +45.3% |
| Q2 FY2024CQ1 2024 | Apr 30, 2024 | $669.00K | +113.1% |
| Q1 FY2024CQ4 2023 | Jan 31, 2024 | $663.00K | +2219.2% |
| Q4 FY2023CQ3 2023 | Oct 31, 2023 | $657.00K | +505.7% |
| Q3 FY2023CQ2 2023 | Jul 31, 2023 | $468.05K | +233.3% |
| Q2 FY2023CQ1 2023 | Apr 30, 2023 | $314.00K | +366.4% |
| Q4 FY2022CQ3 2022 | Oct 31, 2022 | $28.59K | -81.3% |
| Q1 FY2022CQ4 2021 | Jan 31, 2022 | $108.46K | -34.6% |
| Q4 FY2021CQ3 2021 | Oct 31, 2021 | $140.43K | -20.8% |
| Q4 FY2020CQ3 2020 | Oct 31, 2020 | $67.32K | – |
| Q4 FY2019CQ3 2019 | Oct 31, 2019 | $153.18K | – |
| Q3 FY2019CQ2 2019 | Jul 31, 2019 | $165.78K | – |
| Q2 FY2019CQ1 2019 | Apr 30, 2019 | $177.40K | – |
| Q4 FY2018CQ3 2018 | Oct 31, 2018 | $0 | – |
See a number that looks wrong?